Efficacy and tolerability of adjunctive perampanel treatment in children under 12 years of age with refractory epilepsy.

Conclusion: Perampanel offers a treatment option for refractory epilepsy in children as in adults. Adjunctive treatment with perampanel requires special consideration in those with underlying medical conditions to prevent serious adverse events. PMID: 30590000 [PubMed - as supplied by publisher]
Source: Korean Journal of Pediatrics - Category: Pediatrics Tags: Korean J Pediatr Source Type: research